Neurocranial Emboli Removal Systems with Artificial Intelligence and Robotics

The present inventive concept relates to a next-generation system for neurocranial emboli removal, integrating catheter-based emboli removal devices with artificial intelligence-powered navigation, micro-robotic systems, and real-time imaging for enhanced precision and efficacy.

The original patent's minimally invasive catheter and methods of minimally invasive catheter delivered embolic capture devices have limitations in terms of precision, efficacy, and complexity. The present inventive concept addresses these limitations by incorporating advanced technologies to provide a more efficient, precise, and automated system for neurocranial emboli removal.

The inventive concept comprises a catheter-based emboli removal device with a self-expanding mesh basket and an artificial intelligence-powered navigation system for real-time emboli tracking and optimized device deployment. The device is integrated with a micro-robotic system for emboli dislodgement and removal, and utilizes machine learning algorithms to predict and prevent distal complications. The system also features a real-time imaging system for enhanced visualization and precision. In an alternative embodiment, the device can be configured with a hybrid catheter-robotic system with a flexible, shape-memory alloy-based emboli removal device.

The new claims introduce the integration of artificial intelligence, micro-robotics, and real-time imaging, which are not present in the original patent. These advancements provide a significant improvement in precision, efficacy, and automation, making the inventive concept novel and non-obvious compared to the original patent.

Other embodiments of the inventive concept could include the use of nanotechnology-enhanced mesh baskets, onboard computer systems with advanced machine learning algorithms for autonomous navigation, and real-time feedback from a patient's vital signs to optimize device performance. The inventive concept could also be adapted for treating pulmonary embolism or other vascular diseases.

The inventive concept has significant commercial potential in the medical device industry, particularly in the areas of neurointerventional and cardiovascular medicine. The target market includes hospitals, clinics, and medical research institutions, with potential for expansion into other vascular disease treatment areas.